RobertT.MorrisMD

Obstetrics & Gynecology • Grosse Pointe Woods, MI

Gynecologic Oncology

Professor and Director, Division of Gynecologic Oncology, Wayne State University

Join to view full profile

Dr. Morris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Morris' full profile

Already have an account?

Office
19229 Mack Ave
Ste 39
Grosse Pointe Woods, MI 48236
Phone+1 313-647-3243

Fax+1 313-647-3244
Is this information wrong?

Education & Training

Detroit Medical Center/Wayne State UniversityResidency, Obstetrics and Gynecology, 1988 - 1994
University of Minnesota Medical SchoolClass of 1988

Certifications & Licensure

NV State Medical License Current
MI State Medical License 1989 - 2026
TX State Medical License 1994 - 1997
ME State Medical License Active through 1966
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Super Doctor SuperDoctors.com

Clinical Trials

Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer Start of enrollment: 2004 Feb 01
Completed
Phase 2
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease Start of enrollment: 2006 Mar 01
Unknown status
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
Active, not recruiting
Phase 2
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 Apr 29
Active, not recruiting
Phase 2
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2014 Jul 21
Active, not recruiting
Phase 2
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma Start of enrollment: 2017 Jun 22
Recruiting
Phase 2
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Platinum-doublet + Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (OnPrime, GOG-3076) Start of enrollment: 2022 Aug 31
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer.
Ghassan M Saed, Asad Nawaz, Ayesha A Alvero, Amy K Harper, Robert T Morris> ;Biomarkers. 2023 Dec 1
1 citations
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...
Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
The potential benefits of dinitrophenol combination with chemotherapy in the treatment of ovarian cancer.
Nicole M Fletcher, Thea K Kirsch-Mangu, Mohammed Obeidat, Robert Morris, Ghassan M Saed> ;Minerva Obstetrics and Gynecology. 2022 Oct 18
Decreased incidence of febrile neutropenia in Michigan following masking and social distancing orders for the COVID-19 pandemic: A population based cohort study.
Michael Gerard Baracy Jr, Karen Hagglund, Sanjana Kulkarni, Fareeza Afzal, Katherine Arends, Robert T Morris, Leigh Ann Solomon, Muhammad Faisal Aslam, Logan Corey> ;World Journal of Clinical Oncology. 2022 Jul 24
1 citations
Binding of Intracellular Myeloperoxidase to αV/β1 Integrin Serves as a Mechanism of Survival in Epithelial Ovarian Cancer.
Amy K Harper, Thea K Kirsch-Mangu, Hala Lutfi, Robert T Morris, Ghassan M Saed> ;Reproductive Sciences. 2023 Jan 1
9 citations
Molecular profiles of endometrial cancer tumors among Black patients.
Annelise M Wilhite, Yasmine Baca, Joanne Xiu, Rajesh Paladugu, Adam C ElNaggar, Jubilee Brown, Ira S Winer, Robert Morris, Britt K Erickson, Alexander B Olawaiye, Matt...> ;Gynecologic Oncology. 2022 Jul 1
Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells.
Amy K Harper, Xin Wang, Rong Fan, Thea K Mangu, Nicole M. Fletcher, Robert T. Morris, Ghassan M. Saed> ;Minerva Obstetrics and Gynecology. 2021 Nov 26
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Lari Wenzel, Helen Q. Huang, David Cella, Chelsea O. McKinney, Michael A. Zevon, Jason A. Lachance, Joan L. Walker, Ritu Salani, Susan C. Modesitt, Robert T. Morris, W...> ;Gynecologic Oncology. 2021 Sep 20
7 citations
Impact of positive cytology in uterine serous carcinoma: A reassessment
Logan Corey, Juliana Fucinari, Mohamed A. Elshaikh, Daniel Schultz, Rami Mussallam, Feras Zaiem, Fayez Daaboul, Omar Fehmi, Greg Dyson, Julie J. Ruterbusch, Robert T. ...> ;Gynecologic Oncology Reports. 2021 Jul 12
26 citations
Ovarian Cancer modulates the immunosuppressive function of CD11b + Gr1 + myeloid cells via glutamine metabolism.
Mary Priyanka Udumula, Sharif Sakr, Sajad Ahmad Dar, Ayesha B. Alvero, Rouba Ali-Fehmi, Eman Abdulfatah, Jing Li, Jun Jiang, Amy Tang, Thomas Buekers, Robert T. Morris...> ;Molecular Metabolism. 2021 Jun 16
10 citations
Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination defic...
John J. Wallbillich, Robert T. Morris, Rouba Ali-Fehmi> ;Gynecologic Oncology. 2020 Nov 1
1 citations
Molecular Basis Supporting the Association of Talcum Powder Use with Increased Risk of Ovarian Cancer.
Nicole M Fletcher, Amy K Harper, Ira Memaj, Rong Fan, Robert T Morris, Ghassan M Saed> ;Reproductive Sciences. 2020 Oct 1
18 citations
Glyphosate Induces Metaphase II Oocyte Deterioration and Embryo Damage by Zinc Depletion and Overproduction of Reactive Oxygen Species
Zeina A. Yahfoufi, David Bai, Sana N. Khan, Charalampos Chatzicharalampous, Hamid Reza Kohan-Ghadr, Robert T. Morris, Husam M. Abu-Soud> ;Toxicology. 2020 Apr 19
7 citations
Heat Shock Protein 60 (HSP60) Serves as a Potential Target for the Sensitization of Chemoresistant Ovarian Cancer Cells
Amy K Harper, Nicole M. Fletcher, Rong Fan, Robert T. Morris, Ghassan M. Saed> ;Reproductive Sciences. 2020 Mar 2
1 citations
The inhibition of lactoperoxidase catalytic activity through mesna (2-mercaptoethane sodium sulfonate).
Seyedehameneh Jahanbakhsh, Mihir S. Dekhne, Hamid Reza Kohan-Ghadr, David Bai, Awoniyi O. Awonuga, Robert T. Morris, Zhe Yang, Husam M. Abu-Soud> ;Journal of Inorganic Biochemistry. 2020 Feb 1
10 citations
Hypochlorous acid reversibly inhibits caspase-3: a potential regulator of apoptosis.
Roohi Jeelani, Charalampos Chatzicharalampous, Hamid Reza Kohan-Ghadr, David Bai, Robert T. Morris, Inga Sliskovic, Awoniyi O. Awonuga, Husam M. Abu-Soud> ;Free Radical Research. 2020 Jan 7
39 citations
Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.
Eman Abdulfatah, Erin Wakeling, Sharif Sakr, Khaleel I Al-Obaidy, Sudeshna Bandyopadhyay, Robert T. Morris, Gerald L. Feldman, Rouba Ali-Fehmi> ;Gynecologic Oncology. 2019 Sep 1
8 citations
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS...
Nick M. Spirtos, Danielle Enserro, Howard D. Homesley, Susan K. Gibbons, David Cella, Robert T. Morris, Koen DeGeest, Roger B. Lee, David Miller> ;Gynecologic Oncology. 2019 Jul 1
8 citations
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
Batoul Farran, Samet Albayrak, Judith Abrams, Michael A. Tainsky, Nancy Levin, Robert T. Morris, Larry H. Matherly, Manohar Ratnam, Ira Winer> ;Cancer Medicine. 2019 Mar 1
4 citations
Molecular Basis Supporting the Association of Talcum Powder Use With Increased Risk of Ovarian Cancer.
Nicole M Fletcher, Amy K Harper, Ira Memaj, Rong Fan, Robert T Morris, Ghassan M Saed> ;Reproductive Sciences. 2019 Dec 1
11 citations
Acrolein, a commonly found environmental toxin, causes oocyte mitochondrial dysfunction and negatively affects embryo development.
Roohi Jeelani, Charalampos Chatzicharalampous, Hamid Reza Kohan-Ghadr, Awoniyi O. Awonuga, Narendra J. Joshi, Robert T. Morris, Husam M. Abu-Soud> ;Free Radical Research. 2018 Oct 12
14 citations
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Vivian E. von Gruenigen, Helen Q. Huang, David Cella, Michael A. Zevon, Jason A. Lachance, Joan L. Walker, Ritu Salani, Susan C. Modesitt, Robert T. Morris, William H....> ;Gynecologic Oncology. 2018 Jul 1
24 citations
Melatonin prevents hypochlorous acid‐mediated cyanocobalamin destruction and cyanogen chloride generation
Roohi Jeelani, Dhiman Maitra, Charalampos Chatzicharalampous, Syed Najeemuddin, Robert T. Morris, Husam M. Abu-Soud> ;Journal of Pineal Research. 2018 Apr 1
11 citations
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target
Ghassan M. Saed, Nicole M. Fletcher, Michael P. Diamond, Robert T. Morris, Nardhy Gomez-Lopez, Ira Memaj> ;Gynecologic Oncology. 2018 Mar 1
6 citations
Dimercapto-1-propanesulfonic acid (DMPS) induces metaphase II mouse oocyte deterioration.
Sarah R. Aldhaheri, Roohi Jeelani, Hamid Reza Kohan-Ghadr, Sana N. Khan, Sasha Mikhael, Christina Washington, Robert T. Morris, Husam M. Abu-Soud> ;Free Radical Biology & Medicine. 2017 Nov 1
Join now to see all

Hospital Affiliations

Ascension St. John HospitalGrosse Pointe, Michigan
DMC Detroit Receiving Hospital & University Health CenterDetroit, Michigan
DMC Harper University HospitalDetroit, Michigan
Karmanos Cancer CenterDetroit, Michigan